Cyclobenzaprine for the treatment of myofascial pain

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2008, Pages

  Leite, Frederico M G ^a   Atallah, A N ^a   El Dib, R P ^a   Grossmann, E ^a   Januzzi, E ^a   Da Silva, E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOBENZAPRINE; PLACEBO;

AGITATION; CLINICAL TRIAL; COMPARATIVE STUDY; DATA ANALYSIS; DATA EXTRACTION; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERTENSION; HYPOTENSION; INTERVENTION STUDY; LETHARGY; METHODOLOGY; MYOFASCIAL PAIN; OUTCOME ASSESSMENT; PHYSIOTHERAPY; QUALITY OF LIFE; REVIEW; SENSITIVITY ANALYSIS; SHORT FORM 36; SIDE EFFECT; SINUS TACHYCARDIA; VISUAL ANALOG SCALE;

EID: 44949229423     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006830.pub2     Document Type: Review

References (32)

1. Al-Ani 2005 Al-Ani Z, Gray RJ, Davies SJ, Sloan P, Glenny AM. Stabilization splint therapy for the treatment of temporomandibular myofascial pain: a systematic review. Journal of Dental Education 2005;69(11):1242-50. [MEDLINE: 16275687].
2. De Lucena 2006 De Lucena LB, Kosminsky M, da Costa LJ, de Goes PS. Validation of the Portuguese version of the RDC/TMD Axis II questionnaire. Pesquisa Odontológica Brasileira - BrazilianOral Research 2006;20(4):312-7. [MEDLINE: 17242791].
3. DerSimonian 1986 DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;4(3):177-88.
4. Dworkin 1992 Dworkin SF, LeResche L. Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. Journal of Craniomandibular Disorders: Facial & Oral Pain 1992;6(4):301-55. [MEDLINE: 1298767].
5. Fishbain 1986 Fishbain DA, Goldberg M, Meagher BR, et al.Male and female chronic pain patients categorized by DSM-III psychiatric diagnostic criteria. Pain 1986;26:181-197.
6. Fricton 1985 Fricton JR, Kroening R, Haley D, Siegert R. Myofascial pain syndrome of the head and neck: A review of clinical characteristics of 164 patients. Oral Surg Oral Med Oral Pathol 1985;60:615-623.
7. Fricton 1989 Fricton JR, Schiffman EL. Research in temporomandibular disorders. Northwest Dentistry 1989;68(4):29-30. [MEDLINE: 2637428].
8. Gerwin 1995 Gerwin RDA. Study of 96 subjects examined both for fibromyalgia and myofascial pain. J Musculoske Pain 1995;3 (suppl 1):121.
9. Graff-Radford 1984 Graff-Radford B. Myofascial trigger-points: their importance and diagnosis in dental office. Journal of the Dental Association in South Africa 1984;39:237-240.
10. Higgins 2003 Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. BMJ 2003;327:555-7.
11. Higgins 2006 Higgins JPT, Green S, editors. Assessment of study quality. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]; section 6. The Cochrane Library. Chichester, UK: John Wiley & Sons, Ltd, 2007.
12. Jüni 1999 Jüni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. The Journal of the American Medical Association 1999;282(11):1054-60.
13. Kobayashi 1996 Kobayashi H, Hasegawa Y, Ono H. Cyclobenzaprine, a centrally acting muscle relaxant, acts on descending serotonergic systems. European Journal of Pharmacology 1996;311(1):29-35.
14. Koh 2003 Koh H, Robinson PG. Occlusal adjustment for treating and preventing temporomandibular joint disorders. Cochrane Database of Systematic Reviews 2003, Issue 1.Art. No.: CD003812. DOI:10.1002/14651858.CD003812. [MEDLINE: 12535488].
15. Lance 1964 Lance JW, Curran DA. Treatment of chronic tension headache. Lancet 1964;42:1236-9. [MEDLINE: 14152626].
16. Lance 1972 Lance JW, Anthony M. Cyclobenzaprine in the treatment of chronic tension headache. The Medical Journal of Australia 1972;2(25):1409-11. [MEDLINE: 5819771].
17. Laskin 1969 Laskin DM. Etiology of the pain-dysfunction syndrome. Journal of the American Dental Association 1969;79(1):147-53. [MEDLINE: 5254545].
18. List 1996 List T, Dworkin SF.Comparing TMD diagnoses and clinical findings at Swedish and US TMD centers using research diagnostic criteria for temporomandibular disorders. Journal of Orofacial Pain 1996;10(3):240-53. [MEDLINE: 9161229].
19. List 1999 List T, Wahlund K, Wenneberg B, Dworkin SF. TMD in children and adolescents: prevalence of pain, gender differences, and perceived treatment need. Journal of Orofacial Pain 1999;13(1):9-20. [MEDLINE: 10425964].
20. Manfredini 2006 Manfredini D, Chiappe G, Bosco M. Research diagnostic criteria for temporomandibular disorders (RDC/TMD) axis I diagnoses in an Italian patient population. Journal of Oral Rehabilitation 2006;33(8):551-8. [MEDLINE: 16856952].
21. McMillan 1997 McMillan AS, Nolan A, Kelly PJ. The efficacy of dry needling and procaine in the treatment ofmyofascial pain in the jawmuscles. Journal of Orofacial Pain 1997;11(4):307-14. [MEDLINE: 9656906].
22. Okeson 1998 Okeson JP. Orofacial Pain: Guidelines for assessment, Diagnosis and Management. Quintessence Publishing Co Inc, 1998.
23. Okeson 2006 Okeson JP. Bell's Orofacial Pain. 6. São Paulo: Quintessence publishing Co, Inc, 2006.
24. Pertes 2005 Pertes RA, Gross SG. Clinical Management Of Temporomandibular Disorders and Orofacial Pain. Quintessence Publishing Co. Inc, 2005.
25. Reitinger 1996 Reitinger A, Radner H, Tilscher H, et al.Morphologic study of trigger-points. Manuelle Medizin 1996;34:256-262.
26. Schiffman 1990 Schiffman EL, Fricton JR, Haley DP, et al.The prevalence and treatment needs of subjects with temporomandibular disorders. Journal of the American Dental Association 1990;120:295-303.
27. Shi 2003 Shi Z, Guo C, Awad M. Hyaluronate for temporomandibular joint disorders. Cochrane Database of Systematic Reviews 2003, Issue 1.Art. No.: CD002970. DOI: 10.1002/14651858.CD002970.[MEDLINE: 12535445].
28. Simons 2005 Simons DG, Travell JG, Simons LS. Travell & Simons Myofascial Pain and Dysfunction: The Trigger Point Manual. 2. Vol. 1, Sao Paulo: ArtMed, 2005.
29. Solberg 1986 Solberg WK. Temporomandibular disorders: masticatory myalgia and its management. British Dental Journal 1986;160(10): 351-6. [MEDLINE: 3459485].
30. Travell 1952 Travell J, Rinzler SH. The myofascial genesis of pain. Postgraduate Medicine 1952;11(5):425-34. [MEDLINE: 15509460].
31. Unnebrink 2001 Unnebrink K, Windeler J. Intention-to-treat methods for dealing with missing values in clinical trials of progressively deteriorating diseases. Statistics in Medicine 2001;20(24):3931- 46.
32. Yap 2003 Yap AU, Dworkin SF, Chua EK, List T, Tan KB, Tan HH. Prevalence of temporomandibular disorder subtypes, psychologic distress, and psychosocial dysfunction in Asian patients. Journal of Orofacial Pain 2003;17(1):21-8. [MEDLINE: 12756927].